[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Scopolamine Market Insights, Forecast to 2026

June 2020 | 115 pages | ID: GC89641CB174EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
Alkaloids of Australia, Boehringer Ingelheim and Fine Chemicals Corporation, the major players in the industry, accounted for 22.49%, 21.25% and 11.20% of the revenue in 2019, respectively. By region, Australia has the highest share of regional income, reaching 31.18% in 2019.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Scopolamine 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Scopolamine 3900 industry.
Based on our recent survey, we have several different scenarios about the Scopolamine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 10 million in 2019. The market size of Scopolamine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Scopolamine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Scopolamine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Scopolamine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Scopolamine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Scopolamine market, covering important regions, viz, Europe, China, Australia, South Africa and India. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Scopolamine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Scopolamine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Scopolamine market.
The following manufacturers are covered in this report:
  • Alkaloids of Australia
  • Boehringer Ingelheim
  • Fine Chemicals Corporation
  • Phytex Australia
  • Alchem International
  • Guangzhou Hanfang
  • Alkaloids Corporation
  • Luyin
Scopolamine Breakdown Data by Type
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Scopolamine Base
Scopolamine Breakdown Data by Application
  • Oral
  • Injection
  • Patches
1 STUDY COVERAGE

1.1 Scopolamine Product Introduction
1.2 Market Segments
1.3 Key Scopolamine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Scopolamine Market Size Growth Rate by Type
  1.4.2 Scopolamine Butylbromide
  1.4.3 Scopolamine Hydrobromide
  1.4.4 Scopolamine Base
1.5 Market by Application
  1.5.1 Global Scopolamine Market Size Growth Rate by Application
  1.5.2 Oral
  1.5.3 Injection
  1.5.4 Patches
1.6 Coronavirus Disease 2019 (Covid-19): Scopolamine Industry Impact
  1.6.1 How the Covid-19 is Affecting the Scopolamine Industry
    1.6.1.1 Scopolamine Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Scopolamine Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Scopolamine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Scopolamine Market Size Estimates and Forecasts
  2.1.1 Global Scopolamine Revenue 2015-2026
  2.1.2 Global Scopolamine Sales 2015-2026
2.2 Scopolamine Market Size by Region: 2020 Versus 2026
  2.2.1 Global Scopolamine Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Scopolamine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL SCOPOLAMINE COMPETITOR LANDSCAPE BY PLAYERS

3.1 Scopolamine Sales by Manufacturers
  3.1.1 Scopolamine Sales by Manufacturers (2015-2020)
  3.1.2 Scopolamine Sales Market Share by Manufacturers (2015-2020)
3.2 Scopolamine Revenue by Manufacturers
  3.2.1 Scopolamine Revenue by Manufacturers (2015-2020)
  3.2.2 Scopolamine Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Scopolamine Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Scopolamine Revenue in 2019
  3.2.5 Global Scopolamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Scopolamine Price by Manufacturers
3.4 Scopolamine Manufacturing Base Distribution, Product Types
  3.4.1 Scopolamine Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Scopolamine Product Type
  3.4.3 Date of International Manufacturers Enter into Scopolamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Scopolamine Market Size by Type (2015-2020)
  4.1.1 Global Scopolamine Sales by Type (2015-2020)
  4.1.2 Global Scopolamine Revenue by Type (2015-2020)
  4.1.3 Scopolamine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Scopolamine Market Size Forecast by Type (2021-2026)
  4.2.1 Global Scopolamine Sales Forecast by Type (2021-2026)
  4.2.2 Global Scopolamine Revenue Forecast by Type (2021-2026)
  4.2.3 Scopolamine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Scopolamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Scopolamine Market Size by Application (2015-2020)
  5.1.1 Global Scopolamine Sales by Application (2015-2020)
  5.1.2 Global Scopolamine Revenue by Application (2015-2020)
  5.1.3 Scopolamine Price by Application (2015-2020)
5.2 Scopolamine Market Size Forecast by Application (2021-2026)
  5.2.1 Global Scopolamine Sales Forecast by Application (2021-2026)
  5.2.2 Global Scopolamine Revenue Forecast by Application (2021-2026)
  5.2.3 Global Scopolamine Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Scopolamine by Country
  6.1.1 North America Scopolamine Sales by Country
  6.1.2 North America Scopolamine Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Scopolamine Market Facts & Figures by Type
6.3 North America Scopolamine Market Facts & Figures by Application

7 EUROPE

7.1 Europe Scopolamine by Country
  7.1.1 Europe Scopolamine Sales by Country
  7.1.2 Europe Scopolamine Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Scopolamine Market Facts & Figures by Type
7.3 Europe Scopolamine Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Scopolamine by Region
  8.1.1 Asia Pacific Scopolamine Sales by Region
  8.1.2 Asia Pacific Scopolamine Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Scopolamine Market Facts & Figures by Type
8.3 Asia Pacific Scopolamine Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Scopolamine by Country
  9.1.1 Latin America Scopolamine Sales by Country
  9.1.2 Latin America Scopolamine Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Scopolamine Market Facts & Figures by Type
9.3 Central & South America Scopolamine Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Scopolamine by Country
  10.1.1 Middle East and Africa Scopolamine Sales by Country
  10.1.2 Middle East and Africa Scopolamine Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 UAE
10.2 Middle East and Africa Scopolamine Market Facts & Figures by Type
10.3 Middle East and Africa Scopolamine Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Alkaloids of Australia
  11.1.1 Alkaloids of Australia Corporation Information
  11.1.2 Alkaloids of Australia Description, Business Overview and Total Revenue
  11.1.3 Alkaloids of Australia Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Alkaloids of Australia Scopolamine Products Offered
  11.1.5 Alkaloids of Australia Recent Development
11.2 Boehringer Ingelheim
  11.2.1 Boehringer Ingelheim Corporation Information
  11.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
  11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Boehringer Ingelheim Scopolamine Products Offered
  11.2.5 Boehringer Ingelheim Recent Development
11.3 Fine Chemicals Corporation
  11.3.1 Fine Chemicals Corporation Corporation Information
  11.3.2 Fine Chemicals Corporation Description, Business Overview and Total Revenue
  11.3.3 Fine Chemicals Corporation Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Fine Chemicals Corporation Scopolamine Products Offered
  11.3.5 Fine Chemicals Corporation Recent Development
11.4 Phytex Australia
  11.4.1 Phytex Australia Corporation Information
  11.4.2 Phytex Australia Description, Business Overview and Total Revenue
  11.4.3 Phytex Australia Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Phytex Australia Scopolamine Products Offered
  11.4.5 Phytex Australia Recent Development
11.5 Alchem International
  11.5.1 Alchem International Corporation Information
  11.5.2 Alchem International Description, Business Overview and Total Revenue
  11.5.3 Alchem International Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Alchem International Scopolamine Products Offered
  11.5.5 Alchem International Recent Development
11.6 Guangzhou Hanfang
  11.6.1 Guangzhou Hanfang Corporation Information
  11.6.2 Guangzhou Hanfang Description, Business Overview and Total Revenue
  11.6.3 Guangzhou Hanfang Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Guangzhou Hanfang Scopolamine Products Offered
  11.6.5 Guangzhou Hanfang Recent Development
11.7 Alkaloids Corporation
  11.7.1 Alkaloids Corporation Corporation Information
  11.7.2 Alkaloids Corporation Description, Business Overview and Total Revenue
  11.7.3 Alkaloids Corporation Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Alkaloids Corporation Scopolamine Products Offered
  11.7.5 Alkaloids Corporation Recent Development
11.8 Luyin
  11.8.1 Luyin Corporation Information
  11.8.2 Luyin Description, Business Overview and Total Revenue
  11.8.3 Luyin Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Luyin Scopolamine Products Offered
  11.8.5 Luyin Recent Development
11.1 Alkaloids of Australia
  11.1.1 Alkaloids of Australia Corporation Information
  11.1.2 Alkaloids of Australia Description, Business Overview and Total Revenue
  11.1.3 Alkaloids of Australia Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Alkaloids of Australia Scopolamine Products Offered
  11.1.5 Alkaloids of Australia Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Scopolamine Market Estimates and Projections by Region
  12.1.1 Global Scopolamine Sales Forecast by Regions 2021-2026
  12.1.2 Global Scopolamine Revenue Forecast by Regions 2021-2026
12.2 North America Scopolamine Market Size Forecast (2021-2026)
  12.2.1 North America: Scopolamine Sales Forecast (2021-2026)
  12.2.2 North America: Scopolamine Revenue Forecast (2021-2026)
  12.2.3 North America: Scopolamine Market Size Forecast by Country (2021-2026)
12.3 Europe Scopolamine Market Size Forecast (2021-2026)
  12.3.1 Europe: Scopolamine Sales Forecast (2021-2026)
  12.3.2 Europe: Scopolamine Revenue Forecast (2021-2026)
  12.3.3 Europe: Scopolamine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Scopolamine Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Scopolamine Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Scopolamine Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Scopolamine Market Size Forecast by Region (2021-2026)
12.5 Latin America Scopolamine Market Size Forecast (2021-2026)
  12.5.1 Latin America: Scopolamine Sales Forecast (2021-2026)
  12.5.2 Latin America: Scopolamine Revenue Forecast (2021-2026)
  12.5.3 Latin America: Scopolamine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Scopolamine Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Scopolamine Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Scopolamine Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Scopolamine Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Scopolamine Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Scopolamine Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details

LIST OF TABLES

Table 1. Scopolamine Market Segments
Table 2. Ranking of Global Top Scopolamine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Scopolamine Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Scopolamine Butylbromide
Table 5. Major Manufacturers of Scopolamine Hydrobromide
Table 6. Major Manufacturers of Scopolamine Base
Table 7. COVID-19 Impact Global Market: (Four Scopolamine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Scopolamine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Scopolamine Players to Combat Covid-19 Impact
Table 12. Global Scopolamine Market Size Growth Rate by Application 2020-2026 (Kg)
Table 13. Global Scopolamine Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 14. Global Scopolamine Sales by Regions 2015-2020 (Kg)
Table 15. Global Scopolamine Sales Market Share by Regions (2015-2020)
Table 16. Global Scopolamine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Scopolamine Sales by Manufacturers (2015-2020) (Kg)
Table 18. Global Scopolamine Sales Share by Manufacturers (2015-2020)
Table 19. Global Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Scopolamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Scopolamine as of 2019)
Table 21. Scopolamine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Scopolamine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Scopolamine Price (2015-2020) (US$/Kg)
Table 24. Scopolamine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Scopolamine Product Type
Table 26. Date of International Manufacturers Enter into Scopolamine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Scopolamine Sales by Type (2015-2020) (Kg)
Table 29. Global Scopolamine Sales Share by Type (2015-2020)
Table 30. Global Scopolamine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Scopolamine Revenue Share by Type (2015-2020)
Table 32. Scopolamine Average Selling Price (ASP) by Type 2015-2020 (US$/Kg)
Table 33. Global Scopolamine Sales by Application (2015-2020) (Kg)
Table 34. Global Scopolamine Sales Share by Application (2015-2020)
Table 35. North America Scopolamine Sales by Country (2015-2020) (Kg)
Table 36. North America Scopolamine Sales Market Share by Country (2015-2020)
Table 37. North America Scopolamine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Scopolamine Revenue Market Share by Country (2015-2020)
Table 39. North America Scopolamine Sales by Type (2015-2020) (Kg)
Table 40. North America Scopolamine Sales Market Share by Type (2015-2020)
Table 41. North America Scopolamine Sales by Application (2015-2020) (Kg)
Table 42. North America Scopolamine Sales Market Share by Application (2015-2020)
Table 43. Europe Scopolamine Sales by Country (2015-2020) (Kg)
Table 44. Europe Scopolamine Sales Market Share by Country (2015-2020)
Table 45. Europe Scopolamine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Scopolamine Revenue Market Share by Country (2015-2020)
Table 47. Europe Scopolamine Sales by Type (2015-2020) (Kg)
Table 48. Europe Scopolamine Sales Market Share by Type (2015-2020)
Table 49. Europe Scopolamine Sales by Application (2015-2020) (Kg)
Table 50. Europe Scopolamine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Scopolamine Sales by Region (2015-2020) (Kg)
Table 52. Asia Pacific Scopolamine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Scopolamine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Scopolamine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Scopolamine Sales by Type (2015-2020) (Kg)
Table 56. Asia Pacific Scopolamine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Scopolamine Sales by Application (2015-2020) (Kg)
Table 58. Asia Pacific Scopolamine Sales Market Share by Application (2015-2020)
Table 59. Latin America Scopolamine Sales by Country (2015-2020) (Kg)
Table 60. Latin America Scopolamine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Scopolamine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Scopolamine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Scopolamine Sales by Type (2015-2020) (Kg)
Table 64. Latin America Scopolamine Sales Market Share by Type (2015-2020)
Table 65. Latin America Scopolamine Sales by Application (2015-2020) (Kg)
Table 66. Latin America Scopolamine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Scopolamine Sales by Country (2015-2020) (Kg)
Table 68. Middle East and Africa Scopolamine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Scopolamine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Scopolamine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Scopolamine Sales by Type (2015-2020) (Kg)
Table 72. Middle East and Africa Scopolamine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Scopolamine Sales by Application (2015-2020) (Kg)
Table 74. Middle East and Africa Scopolamine Sales Market Share by Application (2015-2020)
Table 75. Alkaloids of Australia Corporation Information
Table 76. Alkaloids of Australia Description and Major Businesses
Table 77. Alkaloids of Australia Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 78. Alkaloids of Australia Product
Table 79. Alkaloids of Australia Recent Development
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Major Businesses
Table 82. Boehringer Ingelheim Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 83. Boehringer Ingelheim Product
Table 84. Boehringer Ingelheim Recent Development
Table 85. Fine Chemicals Corporation Corporation Information
Table 86. Fine Chemicals Corporation Description and Major Businesses
Table 87. Fine Chemicals Corporation Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 88. Fine Chemicals Corporation Product
Table 89. Fine Chemicals Corporation Recent Development
Table 90. Phytex Australia Corporation Information
Table 91. Phytex Australia Description and Major Businesses
Table 92. Phytex Australia Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 93. Phytex Australia Product
Table 94. Phytex Australia Recent Development
Table 95. Alchem International Corporation Information
Table 96. Alchem International Description and Major Businesses
Table 97. Alchem International Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 98. Alchem International Product
Table 99. Alchem International Recent Development
Table 100. Guangzhou Hanfang Corporation Information
Table 101. Guangzhou Hanfang Description and Major Businesses
Table 102. Guangzhou Hanfang Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 103. Guangzhou Hanfang Product
Table 104. Guangzhou Hanfang Recent Development
Table 105. Alkaloids Corporation Corporation Information
Table 106. Alkaloids Corporation Description and Major Businesses
Table 107. Alkaloids Corporation Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 108. Alkaloids Corporation Product
Table 109. Alkaloids Corporation Recent Development
Table 110. Luyin Corporation Information
Table 111. Luyin Description and Major Businesses
Table 112. Luyin Scopolamine Production (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2015-2020)
Table 113. Luyin Product
Table 114. Luyin Recent Development
Table 115. Global Scopolamine Sales Forecast by Regions (2021-2026) (Kg)
Table 116. Global Scopolamine Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Scopolamine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Scopolamine Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Scopolamine Sales Forecast by Country (2021-2026) (Kg)
Table 120. North America: Scopolamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Scopolamine Sales Forecast by Country (2021-2026) (Kg)
Table 122. Europe: Scopolamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Scopolamine Sales Forecast by Region (2021-2026) (Kg)
Table 124. Asia Pacific: Scopolamine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Scopolamine Sales Forecast by Country (2021-2026) (Kg)
Table 126. Latin America: Scopolamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Scopolamine Sales Forecast by Country (2021-2026) (Kg)
Table 128. Middle East and Africa: Scopolamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Scopolamine Players
Table 133. Scopolamine Customers List
Table 134. Scopolamine Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Scopolamine Product Picture
Figure 2. Global Scopolamine Sales Market Share by Type in 2020 & 2026
Figure 3. Scopolamine Butylbromide Product Picture
Figure 4. Scopolamine Hydrobromide Product Picture
Figure 5. Scopolamine Base Product Picture
Figure 6. Global Scopolamine Sales Market Share by Application in 2020 & 2026
Figure 7. Oral
Figure 8. Injection
Figure 9. Patches
Figure 10. Scopolamine Report Years Considered
Figure 11. Global Scopolamine Market Size 2015-2026 (US$ Million)
Figure 12. Global Scopolamine Sales 2015-2026 (Kg)
Figure 13. Global Scopolamine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Scopolamine Sales Market Share by Region (2015-2020)
Figure 15. Global Scopolamine Sales Market Share by Region in 2019
Figure 16. Global Scopolamine Revenue Market Share by Region (2015-2020)
Figure 17. Global Scopolamine Revenue Market Share by Region in 2019
Figure 18. Global Scopolamine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Scopolamine Revenue in 2019
Figure 20. Scopolamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Scopolamine Sales Market Share by Type (2015-2020)
Figure 22. Global Scopolamine Sales Market Share by Type in 2019
Figure 23. Global Scopolamine Revenue Market Share by Type (2015-2020)
Figure 24. Global Scopolamine Revenue Market Share by Type in 2019
Figure 25. Global Scopolamine Market Share by Price Range (2015-2020)
Figure 26. Global Scopolamine Sales Market Share by Application (2015-2020)
Figure 27. Global Scopolamine Sales Market Share by Application in 2019
Figure 28. Global Scopolamine Revenue Market Share by Application (2015-2020)
Figure 29. Global Scopolamine Revenue Market Share by Application in 2019
Figure 30. North America Scopolamine Sales Growth Rate 2015-2020 (Kg)
Figure 31. North America Scopolamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Scopolamine Sales Market Share by Country in 2019
Figure 33. North America Scopolamine Revenue Market Share by Country in 2019
Figure 34. U.S. Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 35. U.S. Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 37. Canada Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Scopolamine Market Share by Type in 2019
Figure 39. North America Scopolamine Market Share by Application in 2019
Figure 40. Europe Scopolamine Sales Growth Rate 2015-2020 (Kg)
Figure 41. Europe Scopolamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Scopolamine Sales Market Share by Country in 2019
Figure 43. Europe Scopolamine Revenue Market Share by Country in 2019
Figure 44. Germany Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 45. Germany Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 47. France Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 49. U.K. Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 51. Italy Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 53. Russia Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Scopolamine Market Share by Type in 2019
Figure 55. Europe Scopolamine Market Share by Application in 2019
Figure 56. Asia Pacific Scopolamine Sales Growth Rate 2015-2020 (Kg)
Figure 57. Asia Pacific Scopolamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Scopolamine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Scopolamine Revenue Market Share by Region in 2019
Figure 60. China Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 61. China Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 63. Japan Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 65. South Korea Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 67. India Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 69. Australia Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 71. Taiwan Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 73. Indonesia Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 75. Thailand Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 77. Malaysia Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 79. Philippines Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 81. Vietnam Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Scopolamine Market Share by Type in 2019
Figure 83. Asia Pacific Scopolamine Market Share by Application in 2019
Figure 84. Latin America Scopolamine Sales Growth Rate 2015-2020 (Kg)
Figure 85. Latin America Scopolamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Scopolamine Sales Market Share by Country in 2019
Figure 87. Latin America Scopolamine Revenue Market Share by Country in 2019
Figure 88. Mexico Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 89. Mexico Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 91. Brazil Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 93. Argentina Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Scopolamine Market Share by Type in 2019
Figure 95. Latin America Scopolamine Market Share by Application in 2019
Figure 96. Middle East and Africa Scopolamine Sales Growth Rate 2015-2020 (Kg)
Figure 97. Middle East and Africa Scopolamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Scopolamine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Scopolamine Revenue Market Share by Country in 2019
Figure 100. Turkey Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 101. Turkey Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 103. Saudi Arabia Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Scopolamine Sales Growth Rate (2015-2020) (Kg)
Figure 105. UAE Scopolamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Scopolamine Market Share by Type in 2019
Figure 107. Middle East and Africa Scopolamine Market Share by Application in 2019
Figure 108. Alkaloids of Australia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Fine Chemicals Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Phytex Australia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Alchem International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Guangzhou Hanfang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Alkaloids Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Luyin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Scopolamine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 117. North America Scopolamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Scopolamine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 119. Europe Scopolamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Scopolamine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 121. Asia Pacific Scopolamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Scopolamine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 123. Latin America Scopolamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Scopolamine Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 125. Middle East and Africa Scopolamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed


More Publications